CIK: 0001193586 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $286,245 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCTY | Paylocity Holding Corporation | 568,412 | $103,280 | 36.1% | $27.51 | +630.1% | Common | 70438V106 |
| RMNI | Rimini Street, Inc. | 23,565,433 | $51,844 | 18.1% | $8.44 | -64.0% | Common | 76674Q107 |
| PDD | PDD Holdings, Inc. | 298,150 | $29,240 | 10.2% | $98.07 | — | ADS | 722304102 |
| QTWO | Q2 Holdings, Inc. | 777,562 | $25,092 | 8.8% | $19.72 | +68.0% | Common | 74736L109 |
| MLYS | Mineralys Therapeutics, Inc. | 2,302,329 | $21,895 | 7.6% | $16.83 | -22.5% | Common | 603170101 |
| — | Vacasa, Inc. | 8,631,670 | $18,765 | 6.6% | $6.75 | — | Common- Class A | 91854V107 |
| — | Icosavax, Inc. | 2,179,964 | $16,895 | 5.9% | $26.63 | — | Common | 45114M109 |
| — | Fusion Pharmaceuticals, Inc. | 2,947,809 | $7,664 | 2.7% | $15.72 | — | Common | 36118A100 |
| CRVS | Corvus Pharmaceuticals, Inc. | 3,275,616 | $4,782 | 1.7% | $13.47 | -84.3% | Common | 221015100 |
| CXM | Sprinklr, Inc. | 214,012 | $2,962 | 1.0% | $14.32 | 0.0% | Common-Class A | 85208T107 |
| PATH | UiPath, Inc. | 113,954 | $1,950 | 0.7% | $16.04 | +3.8% | Common- Class A | 90364P105 |
| FRSH | Freshworks Inc. | 60,862 | $1,212 | 0.4% | $17.47 | +13.7% | Common- Class A | 358054104 |
| AFRM | Affirm Holdings, Inc. | 17,610 | $375 | 0.1% | $18.28 | 0.0% | Common-Class A | 00827B106 |
| BRZE | Braze, Inc. | 6,192 | $289 | 0.1% | $43.95 | 0.0% | Common-Class A | 10576N102 |